Structure

Physi-Chem Properties

Molecular Weight:  446.27
Volume:  478.062
LogP:  4.142
LogD:  3.788
LogS:  -4.833
# Rotatable Bonds:  13
TPSA:  96.2
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.334
Synthetic Accessibility Score:  4.801
Fsp3:  0.538
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.739
MDCK Permeability:  1.6165302440640517e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.167
Human Intestinal Absorption (HIA):  0.94
20% Bioavailability (F20%):  0.367
30% Bioavailability (F30%):  0.583

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.049
Plasma Protein Binding (PPB):  96.21703338623047%
Volume Distribution (VD):  1.985
Pgp-substrate:  1.3214539289474487%

ADMET: Metabolism

CYP1A2-inhibitor:  0.036
CYP1A2-substrate:  0.613
CYP2C19-inhibitor:  0.075
CYP2C19-substrate:  0.576
CYP2C9-inhibitor:  0.606
CYP2C9-substrate:  0.893
CYP2D6-inhibitor:  0.15
CYP2D6-substrate:  0.857
CYP3A4-inhibitor:  0.455
CYP3A4-substrate:  0.369

ADMET: Excretion

Clearance (CL):  7.537
Half-life (T1/2):  0.78

ADMET: Toxicity

hERG Blockers:  0.013
Human Hepatotoxicity (H-HT):  0.775
Drug-inuced Liver Injury (DILI):  0.868
AMES Toxicity:  0.013
Rat Oral Acute Toxicity:  0.957
Maximum Recommended Daily Dose:  0.855
Skin Sensitization:  0.198
Carcinogencity:  0.447
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.965

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476016

Natural Product ID:  NPC476016
Common Name*:   Sarcotin M
IUPAC Name:   (2S)-2-[(2Z,6S,7E)-13-(furan-3-yl)-10-hydroxy-9-methoxy-2,6,10-trimethyltrideca-2,7-dienyl]-3-hydroxy-4-methyl-2H-furan-5-one
Synonyms:   Sarcotin M
Standard InCHIKey:  YWMJHOIHFKZPSI-JYDPISDLSA-N
Standard InCHI:  InChI=1S/C26H38O6/c1-18(8-6-9-19(2)16-22-24(27)20(3)25(28)32-22)11-12-23(30-5)26(4,29)14-7-10-21-13-15-31-17-21/h9,11-13,15,17-18,22-23,27,29H,6-8,10,14,16H2,1-5H3/b12-11+,19-9-/t18-,22-,23?,26?/m0/s1
SMILES:  CC1=C(C(OC1=O)CC(=CCCC(C)C=CC(C(C)(CCCC2=COC=C2)O)OC)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL521754
PubChem CID:   54699424
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33064 sarcotragus sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[11678655]
NPO33064 sarcotragus sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[12350153]
NPO33064 sarcotragus sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[18341287]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 = 9.0 ug ml-1 PMID[543971]
NPT146 Cell Line SK-OV-3 Homo sapiens ED50 = 8.4 ug ml-1 PMID[543971]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 = 9.9 ug ml-1 PMID[543971]
NPT574 Cell Line XF498 Homo sapiens ED50 = 11.3 ug ml-1 PMID[543971]
NPT148 Cell Line HCT-15 Homo sapiens ED50 = 10.1 ug ml-1 PMID[543971]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476016 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9752 High Similarity NPC474279
0.9752 High Similarity NPC474438
0.975 High Similarity NPC474260
0.975 High Similarity NPC329922
0.975 High Similarity NPC81912
0.975 High Similarity NPC329694
0.9504 High Similarity NPC75557
0.9504 High Similarity NPC71274
0.95 High Similarity NPC475818
0.9412 High Similarity NPC474817
0.935 High Similarity NPC474830
0.9339 High Similarity NPC476351
0.9256 High Similarity NPC289911
0.9256 High Similarity NPC283284
0.9206 High Similarity NPC17681
0.9187 High Similarity NPC471559
0.9187 High Similarity NPC474829
0.9174 High Similarity NPC474136
0.916 High Similarity NPC144745
0.916 High Similarity NPC208906
0.9134 High Similarity NPC97740
0.9062 High Similarity NPC474426
0.9062 High Similarity NPC474407
0.9062 High Similarity NPC474425
0.904 High Similarity NPC471554
0.904 High Similarity NPC471501
0.904 High Similarity NPC473355
0.904 High Similarity NPC471573
0.9008 High Similarity NPC473969
0.8984 High Similarity NPC45358
0.8943 High Similarity NPC471549
0.8943 High Similarity NPC473379
0.8889 High Similarity NPC137570
0.8843 High Similarity NPC131801
0.8788 High Similarity NPC170604
0.8788 High Similarity NPC215109
0.8655 High Similarity NPC105249
0.8651 High Similarity NPC243269
0.8583 High Similarity NPC1811
0.8583 High Similarity NPC26157
0.8571 High Similarity NPC303217
0.855 High Similarity NPC471545
0.855 High Similarity NPC473344
0.855 High Similarity NPC471544
0.8516 High Similarity NPC46536
0.8516 High Similarity NPC138139
0.8504 High Similarity NPC65735
0.8504 High Similarity NPC118853
0.8504 High Similarity NPC188377
0.8496 Intermediate Similarity NPC14650
0.8473 Intermediate Similarity NPC89133
0.845 Intermediate Similarity NPC83178
0.8421 Intermediate Similarity NPC288209
0.8413 Intermediate Similarity NPC1848
0.8403 Intermediate Similarity NPC471521
0.8403 Intermediate Similarity NPC473356
0.8385 Intermediate Similarity NPC112706
0.8385 Intermediate Similarity NPC207294
0.8382 Intermediate Similarity NPC107571
0.8374 Intermediate Similarity NPC28054
0.837 Intermediate Similarity NPC473268
0.8358 Intermediate Similarity NPC476947
0.8346 Intermediate Similarity NPC477967
0.8295 Intermediate Similarity NPC179354
0.8281 Intermediate Similarity NPC16922
0.8268 Intermediate Similarity NPC79557
0.8254 Intermediate Similarity NPC4898
0.8248 Intermediate Similarity NPC90953
0.8222 Intermediate Similarity NPC159786
0.8209 Intermediate Similarity NPC218838
0.8203 Intermediate Similarity NPC263870
0.8201 Intermediate Similarity NPC121158
0.8195 Intermediate Similarity NPC298190
0.8182 Intermediate Similarity NPC234494
0.8182 Intermediate Similarity NPC125182
0.8182 Intermediate Similarity NPC177331
0.8182 Intermediate Similarity NPC69647
0.8175 Intermediate Similarity NPC187547
0.8175 Intermediate Similarity NPC21831
0.8169 Intermediate Similarity NPC255414
0.8168 Intermediate Similarity NPC319140
0.8168 Intermediate Similarity NPC95567
0.8143 Intermediate Similarity NPC80635
0.8134 Intermediate Similarity NPC473982
0.8134 Intermediate Similarity NPC471817
0.8102 Intermediate Similarity NPC186626
0.8099 Intermediate Similarity NPC104924
0.8092 Intermediate Similarity NPC74612
0.8092 Intermediate Similarity NPC23086
0.8088 Intermediate Similarity NPC92941
0.8085 Intermediate Similarity NPC307346
0.8085 Intermediate Similarity NPC261733
0.8085 Intermediate Similarity NPC267004
0.8085 Intermediate Similarity NPC251865
0.8085 Intermediate Similarity NPC218712
0.808 Intermediate Similarity NPC150895
0.8077 Intermediate Similarity NPC477965
0.8077 Intermediate Similarity NPC477038
0.8062 Intermediate Similarity NPC317217
0.806 Intermediate Similarity NPC61788
0.806 Intermediate Similarity NPC136340
0.8031 Intermediate Similarity NPC243704
0.8029 Intermediate Similarity NPC146872
0.8016 Intermediate Similarity NPC45536
0.8015 Intermediate Similarity NPC106247
0.8014 Intermediate Similarity NPC268905
0.8014 Intermediate Similarity NPC267632
0.8014 Intermediate Similarity NPC254198
0.8014 Intermediate Similarity NPC476946
0.8014 Intermediate Similarity NPC33938
0.8 Intermediate Similarity NPC470997
0.7986 Intermediate Similarity NPC7388
0.7985 Intermediate Similarity NPC21460
0.7972 Intermediate Similarity NPC346
0.7971 Intermediate Similarity NPC470742
0.797 Intermediate Similarity NPC477966
0.797 Intermediate Similarity NPC477039
0.797 Intermediate Similarity NPC477040
0.797 Intermediate Similarity NPC477123
0.7959 Intermediate Similarity NPC98206
0.7959 Intermediate Similarity NPC253201
0.7959 Intermediate Similarity NPC237259
0.7959 Intermediate Similarity NPC34421
0.7959 Intermediate Similarity NPC302054
0.7958 Intermediate Similarity NPC137295
0.7953 Intermediate Similarity NPC217180
0.7953 Intermediate Similarity NPC312525
0.7943 Intermediate Similarity NPC52412
0.7941 Intermediate Similarity NPC470740
0.7939 Intermediate Similarity NPC130275
0.7929 Intermediate Similarity NPC56197
0.7929 Intermediate Similarity NPC67003
0.7917 Intermediate Similarity NPC216755
0.7917 Intermediate Similarity NPC471174
0.7914 Intermediate Similarity NPC236532
0.791 Intermediate Similarity NPC223063
0.791 Intermediate Similarity NPC120836
0.7905 Intermediate Similarity NPC141538
0.7905 Intermediate Similarity NPC214541
0.7905 Intermediate Similarity NPC155939
0.7905 Intermediate Similarity NPC296807
0.7905 Intermediate Similarity NPC44675
0.7902 Intermediate Similarity NPC195920
0.7902 Intermediate Similarity NPC5676
0.7902 Intermediate Similarity NPC34056
0.7891 Intermediate Similarity NPC294511
0.7891 Intermediate Similarity NPC254958
0.7891 Intermediate Similarity NPC474219
0.7891 Intermediate Similarity NPC474378
0.7891 Intermediate Similarity NPC44577
0.7891 Intermediate Similarity NPC291619
0.7891 Intermediate Similarity NPC121615
0.7891 Intermediate Similarity NPC472672
0.7877 Intermediate Similarity NPC228842
0.7867 Intermediate Similarity NPC472779
0.7862 Intermediate Similarity NPC471007
0.7857 Intermediate Similarity NPC202260
0.7852 Intermediate Similarity NPC476925
0.7852 Intermediate Similarity NPC469485
0.7842 Intermediate Similarity NPC310830
0.7836 Intermediate Similarity NPC327527
0.7836 Intermediate Similarity NPC476917
0.7832 Intermediate Similarity NPC476944
0.7826 Intermediate Similarity NPC158525
0.7815 Intermediate Similarity NPC470789
0.7812 Intermediate Similarity NPC227660
0.7808 Intermediate Similarity NPC470998
0.7808 Intermediate Similarity NPC472654
0.7801 Intermediate Similarity NPC282973
0.7801 Intermediate Similarity NPC90296
0.78 Intermediate Similarity NPC472778
0.78 Intermediate Similarity NPC299038
0.78 Intermediate Similarity NPC470118
0.78 Intermediate Similarity NPC45101
0.78 Intermediate Similarity NPC173544
0.78 Intermediate Similarity NPC261597
0.78 Intermediate Similarity NPC7059
0.78 Intermediate Similarity NPC197137
0.78 Intermediate Similarity NPC472776
0.78 Intermediate Similarity NPC472777
0.78 Intermediate Similarity NPC194499
0.78 Intermediate Similarity NPC88007
0.7795 Intermediate Similarity NPC205523
0.7794 Intermediate Similarity NPC475092
0.7793 Intermediate Similarity NPC302987
0.7793 Intermediate Similarity NPC476938
0.7793 Intermediate Similarity NPC250228
0.7793 Intermediate Similarity NPC476937
0.7786 Intermediate Similarity NPC36255
0.7786 Intermediate Similarity NPC476943
0.7786 Intermediate Similarity NPC220094
0.7785 Intermediate Similarity NPC92979
0.7785 Intermediate Similarity NPC281258
0.7785 Intermediate Similarity NPC264943
0.7778 Intermediate Similarity NPC198904
0.777 Intermediate Similarity NPC46896
0.777 Intermediate Similarity NPC147168
0.7762 Intermediate Similarity NPC22248
0.7762 Intermediate Similarity NPC223415
0.7762 Intermediate Similarity NPC110305

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476016 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7606 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6355 Discontinued
0.7448 Intermediate Similarity NPD4628 Phase 3
0.732 Intermediate Similarity NPD5761 Phase 2
0.732 Intermediate Similarity NPD5760 Phase 2
0.7163 Intermediate Similarity NPD6798 Discontinued
0.7143 Intermediate Similarity NPD6832 Phase 2
0.7122 Intermediate Similarity NPD5647 Approved
0.7103 Intermediate Similarity NPD2799 Discontinued
0.7083 Intermediate Similarity NPD6653 Approved
0.708 Intermediate Similarity NPD9717 Approved
0.6993 Remote Similarity NPD6233 Phase 2
0.6993 Remote Similarity NPD4062 Phase 3
0.6987 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6986 Remote Similarity NPD4308 Phase 3
0.6974 Remote Similarity NPD6273 Approved
0.697 Remote Similarity NPD6764 Approved
0.697 Remote Similarity NPD6765 Approved
0.6964 Remote Similarity NPD8434 Phase 2
0.6933 Remote Similarity NPD2354 Approved
0.6933 Remote Similarity NPD3887 Approved
0.6929 Remote Similarity NPD2797 Approved
0.6923 Remote Similarity NPD2313 Discontinued
0.6917 Remote Similarity NPD690 Clinical (unspecified phase)
0.6913 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6897 Remote Similarity NPD447 Suspended
0.6892 Remote Similarity NPD6004 Phase 3
0.6892 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6892 Remote Similarity NPD6005 Phase 3
0.6892 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6892 Remote Similarity NPD6002 Phase 3
0.687 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6867 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6867 Remote Similarity NPD4110 Phase 3
0.6855 Remote Similarity NPD7075 Discontinued
0.6853 Remote Similarity NPD7095 Approved
0.6846 Remote Similarity NPD5958 Discontinued
0.6842 Remote Similarity NPD6799 Approved
0.6842 Remote Similarity NPD1241 Discontinued
0.6842 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6835 Remote Similarity NPD1608 Approved
0.6831 Remote Similarity NPD9494 Approved
0.6828 Remote Similarity NPD4307 Phase 2
0.6824 Remote Similarity NPD1551 Phase 2
0.6809 Remote Similarity NPD6362 Approved
0.6809 Remote Similarity NPD1203 Approved
0.6806 Remote Similarity NPD3268 Approved
0.6805 Remote Similarity NPD6785 Approved
0.6805 Remote Similarity NPD6784 Approved
0.6803 Remote Similarity NPD7097 Phase 1
0.6779 Remote Similarity NPD2344 Approved
0.6769 Remote Similarity NPD1358 Approved
0.6767 Remote Similarity NPD7843 Approved
0.6766 Remote Similarity NPD6559 Discontinued
0.6765 Remote Similarity NPD9092 Discovery
0.6763 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6761 Remote Similarity NPD1019 Discontinued
0.6761 Remote Similarity NPD2798 Approved
0.6753 Remote Similarity NPD5049 Phase 3
0.6741 Remote Similarity NPD7157 Approved
0.6733 Remote Similarity NPD4534 Discontinued
0.6731 Remote Similarity NPD7458 Discontinued
0.6731 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6718 Remote Similarity NPD2684 Approved
0.6715 Remote Similarity NPD9545 Approved
0.6715 Remote Similarity NPD1894 Discontinued
0.6711 Remote Similarity NPD2935 Discontinued
0.671 Remote Similarity NPD920 Approved
0.671 Remote Similarity NPD5403 Approved
0.6692 Remote Similarity NPD3134 Approved
0.6691 Remote Similarity NPD3496 Discontinued
0.669 Remote Similarity NPD411 Approved
0.669 Remote Similarity NPD6859 Clinical (unspecified phase)
0.669 Remote Similarity NPD3764 Approved
0.6688 Remote Similarity NPD5401 Approved
0.6688 Remote Similarity NPD6599 Discontinued
0.6667 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1933 Approved
0.6667 Remote Similarity NPD2067 Discontinued
0.6667 Remote Similarity NPD2346 Discontinued
0.6667 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6667 Remote Similarity NPD643 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5763 Approved
0.6667 Remote Similarity NPD5762 Approved
0.6667 Remote Similarity NPD2353 Approved
0.6667 Remote Similarity NPD7440 Discontinued
0.6645 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6644 Remote Similarity NPD7033 Discontinued
0.6623 Remote Similarity NPD2424 Discontinued
0.6621 Remote Similarity NPD5952 Clinical (unspecified phase)
0.662 Remote Similarity NPD1876 Approved
0.6619 Remote Similarity NPD17 Approved
0.6619 Remote Similarity NPD1778 Approved
0.6605 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6605 Remote Similarity NPD919 Approved
0.6604 Remote Similarity NPD6801 Discontinued
0.6601 Remote Similarity NPD2309 Approved
0.66 Remote Similarity NPD2240 Approved
0.66 Remote Similarity NPD2239 Approved
0.6599 Remote Similarity NPD4060 Phase 1
0.6584 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6581 Remote Similarity NPD4661 Approved
0.6581 Remote Similarity NPD642 Clinical (unspecified phase)
0.6581 Remote Similarity NPD4662 Approved
0.6573 Remote Similarity NPD3266 Approved
0.6573 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6573 Remote Similarity NPD987 Approved
0.6573 Remote Similarity NPD3267 Approved
0.6569 Remote Similarity NPD9493 Approved
0.6562 Remote Similarity NPD1006 Clinical (unspecified phase)
0.6562 Remote Similarity NPD7819 Suspended
0.6552 Remote Similarity NPD2614 Approved
0.6547 Remote Similarity NPD5585 Approved
0.6541 Remote Similarity NPD6677 Suspended
0.6536 Remote Similarity NPD7003 Approved
0.6536 Remote Similarity NPD3750 Approved
0.6528 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6524 Remote Similarity NPD8127 Discontinued
0.6522 Remote Similarity NPD5402 Approved
0.6515 Remote Similarity NPD290 Approved
0.6506 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6503 Remote Similarity NPD1283 Approved
0.649 Remote Similarity NPD6032 Approved
0.649 Remote Similarity NPD4476 Approved
0.649 Remote Similarity NPD1501 Clinical (unspecified phase)
0.649 Remote Similarity NPD4477 Approved
0.649 Remote Similarity NPD2796 Approved
0.649 Remote Similarity NPD2438 Suspended
0.6481 Remote Similarity NPD7768 Phase 2
0.6481 Remote Similarity NPD3882 Suspended
0.6479 Remote Similarity NPD3972 Approved
0.6479 Remote Similarity NPD1481 Phase 2
0.6474 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6471 Remote Similarity NPD1243 Approved
0.6466 Remote Similarity NPD2182 Approved
0.6454 Remote Similarity NPD3847 Discontinued
0.6447 Remote Similarity NPD1471 Phase 3
0.6442 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6442 Remote Similarity NPD3749 Approved
0.6438 Remote Similarity NPD7411 Suspended
0.6429 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6424 Remote Similarity NPD3748 Approved
0.6423 Remote Similarity NPD2629 Approved
0.642 Remote Similarity NPD3817 Phase 2
0.642 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6419 Remote Similarity NPD8032 Phase 2
0.6415 Remote Similarity NPD2651 Approved
0.6415 Remote Similarity NPD2649 Approved
0.6408 Remote Similarity NPD1535 Discovery
0.6405 Remote Similarity NPD1549 Phase 2
0.6405 Remote Similarity NPD2897 Discontinued
0.6398 Remote Similarity NPD1934 Approved
0.6397 Remote Similarity NPD5535 Approved
0.6395 Remote Similarity NPD2598 Clinical (unspecified phase)
0.6392 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6386 Remote Similarity NPD6808 Phase 2
0.6376 Remote Similarity NPD4140 Approved
0.6376 Remote Similarity NPD3142 Approved
0.6376 Remote Similarity NPD3140 Approved
0.6376 Remote Similarity NPD2979 Phase 3
0.6375 Remote Similarity NPD4380 Phase 2
0.637 Remote Similarity NPD454 Approved
0.6358 Remote Similarity NPD8455 Phase 2
0.6358 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6341 Remote Similarity NPD8005 Clinical (unspecified phase)
0.634 Remote Similarity NPD1552 Clinical (unspecified phase)
0.634 Remote Similarity NPD1550 Clinical (unspecified phase)
0.634 Remote Similarity NPD6800 Clinical (unspecified phase)
0.6335 Remote Similarity NPD958 Approved
0.6333 Remote Similarity NPD4622 Approved
0.6333 Remote Similarity NPD230 Phase 1
0.6333 Remote Similarity NPD4618 Approved
0.6331 Remote Similarity NPD3818 Discontinued
0.6331 Remote Similarity NPD2163 Approved
0.6331 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6325 Remote Similarity NPD7199 Phase 2
0.6324 Remote Similarity NPD969 Suspended
0.6323 Remote Similarity NPD8166 Discontinued
0.6322 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6319 Remote Similarity NPD4359 Approved
0.6319 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6319 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6312 Remote Similarity NPD5691 Approved
0.6312 Remote Similarity NPD3455 Phase 2
0.6312 Remote Similarity NPD3226 Approved
0.6303 Remote Similarity NPD6315 Phase 2
0.6301 Remote Similarity NPD8313 Approved
0.6301 Remote Similarity NPD8312 Approved
0.6299 Remote Similarity NPD970 Clinical (unspecified phase)
0.6299 Remote Similarity NPD7596 Clinical (unspecified phase)
0.6296 Remote Similarity NPD7577 Discontinued
0.6296 Remote Similarity NPD6844 Discontinued
0.6294 Remote Similarity NPD1281 Approved
0.6294 Remote Similarity NPD5844 Phase 1
0.6289 Remote Similarity NPD3873 Phase 3
0.6289 Remote Similarity NPD3869 Phase 3
0.6284 Remote Similarity NPD6863 Phase 2
0.6279 Remote Similarity NPD7685 Pre-registration
0.6276 Remote Similarity NPD3225 Approved
0.6275 Remote Similarity NPD5712 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data